Imperial Innovations
98
11M
58
2.65
34
0.41
17
- Areas of investment
Summary
Imperial Innovations is the famous VC, which was founded in 1986. The company was established in Europe in United Kingdom. The main department of described VC is located in the London.
The real fund results show that this VC is 26 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2016. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2013. The fund is generally included in 2-6 deals every year. Comparing to the other companies, this Imperial Innovations performs on 15 percentage points less the average number of lead investments.
We can highlight the next thriving fund investment areas, such as Health Diagnostics, Artificial Intelligence. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Cell Medica, Circassia, WaveOptics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Besides them, we counted 8 critical employees of this fund in our database.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Imperial Innovations, startups are often financed by Nesta Ventures, Invesco, Sofinnova Partners. The meaningful sponsors for the fund in investment in the same round are Nesta Ventures, SV Health Investors, Woodford Investment Management. In the next rounds fund is usually obtained by Woodford Investment Management, Nesta Ventures, SV Health Investors.
Investments analytics
Analytics
- Total investments
- 98
- Lead investments
- 34
- Exits
- 17
- Rounds per year
- 2.65
- Follow on index
- 0.41
- Investments by industry
- Biotechnology (44)
- Health Care (38)
- Therapeutics (21)
- Medical (21)
- Medical Device (20) Show 100 more
- Investments by region
-
- United Kingdom (92)
- United States (6)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 24M
- Group Appearance index
- 0.79
- Avg. company exit year
- 13
- Avg. multiplicator
- 1.79
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Autifony Therapeutics | 22 Aug 2011 | Biotechnology, Medical Device, Therapeutics | Seed | 13M | England, London, United Kingdom |
| import.io | 12 Jan 2016 | Software, Information Technology, Big Data | Early Stage Venture | 13M | United States, California |
| Thriftify | 28 Oct 2020 | E-Commerce, Retail | Seed | 590K | Dublin, Dublin, Ireland |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.